HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners


News provided by AS Equity Partners on Monday 3rd Aug 2026



Hochdorf, Switzerland – August 2, 2026 – HOCHDORF and Pharmalys are proud to announce the official launch of a new, jointly owned company, Hochdorf Laboratories SA. This strategic joint venture (JV), led by HOCHDORF, is a key milestone in HOCHDORF's transformation, supported by its owner, AS Equity Partners.

The JV combines HOCHDORF’s world-class Swiss production technology and manufacturing expertise with Pharmalys’ powerful brand portfolio and established global market access. By integrating defined activities—including infant nutrition brands, intellectual property, and technical know-how—into one legal entity, the partnership will drive increased efficiency, faster decision-making, and sustainable, profitable growth.

The move aligns with AS Equity Partners’ strategy to leverage HOCHDORF’s operations on scalable, value-adding activities and international growth, while optimizing industrial utilization.

“The formation of this joint venture represents a decisive step forward in our vision for HOCHDORF. AS Equity Partners remains committed to providing the strategic and financial backing necessary to ensure this venture delivers long-term value for all stakeholders,” said Andreas Schulte, Founder and Managing Partner at AS Equity Partners.

“By bridging HOCHDORF’s industrial excellence with Pharmalys’ commercial strength, we are creating a high-performance platform poised for international expansion,” said Amir Mechria, Chairman of the Board at Pharmalys Laboratories.

.

______________________________________________________________________________

About AS Equity Partners: AS Equity Partners is a Zürich and London based private equity firm focused on control investments in mid-market companies within the technology and industrial sectors. The firm specializes in special situations, complex carve-outs and transformational growth, working closely with management teams to drive operational excellence and long-term value creation.

About HOCHDORF Swiss Nutrition: HOCHDORF is a leader in the Swiss market for the development, production, and marketing of high-quality products made from milk and other natural ingredients. and a specialist player in the global infant nutrition industry

About Pharmalys Laboratories: Pharmalys is a Swiss company specialized in premium infant nutrition. Known for its strong brands and extensive distribution network across 32 countries, Pharmalys specializes in delivering high-quality nutrition worldwide,

Media Contact:

Maitri O’Brien, Operating Partner

maitri.obrien@as-equitypartners.com

+41792382199

Press release distributed by Pressat on behalf of AS Equity Partners, on Monday 3 August, 2026. For more information subscribe and follow https://pressat.co.uk/


AS Equity Partners Hochdorf Swiss Nutrition Pharmalys Laboratories Infant Nutrition Swiss Production Food And Nutrition Business & Finance Food & Drink Health Manufacturing, Engineering & Energy Medical & Pharmaceutical
Published By

AS Equity Partners

AS Equity Partners
+44 203 907 4211
[email protected]
https://as-equitypartners.com

Visit Newsroom

Media

No media attached. Please contact AS Equity Partners for more information.


Additional PR Formats


You just read:

HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners

News from this source: